Skip to main content
SpringerLink
Log in

The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing–remitting multiple sclerosis differently in female and male patients

  • Original article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with variable types of disability progression (DP). Previous studies, defining different disability milestones (DMs), have reported symptoms at MS onset to be the predictors of DP and sex as a risk factor. Meanwhile, accounting for sex differences in MS, predictors in female and male patients might differ. To investigate whether the symptoms at MS onset predict reaching DMs in patients with relapsing–remitting (RR) MS and whether the predictors vary between different DMs and female and male patients. Data from 128 RR MS patients (84 females, 44 males) was retrospectively studied. EDSS scores 4 and 6 (associated with impaired ambulation) were taken as DMs. Association between symptoms at MS onset and time to reach DMs was assessed with Cox multiple regression model. Pyramidal symptoms and fatigue at MS onset predicted the progression to EDSS 4 in the whole study population (HR 1.84, 95% CI 1.07–3.2, p = 0.028 and HR 2.01, 95% CI 1.12–3.4, p = 0.011, correspondingly). The same symptoms predicted reaching DM in female, but not male patients. Bowel/bladder symptoms predicted reaching EDSS 6 in the whole study population (HR 4.31, 95% CI 1.47–12.6, p = 0.008) and female patients only (HR 3.93, 95% CI 1.04–14.8, p = 0.043). In female patients, fatigue was also the predictor of reaching EDSS 6 (HR 3.54, 95% CI 1.16–10.8, p = 0.026). Impairment of functional symptoms at MS onset can predict reaching DMs in patients with RR-MS, but the predictors for EDSS 4 and EDSS 6 differ in female and male patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The data used for this study are available from the corresponding author upon reasonable request.

References

  1. Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple sclerosis. Lancet 391:1622–1636. https://doi.org/10.1016/S0140-6736(18)30481-1

    Article  PubMed  Google Scholar 

  2. Goodin DS (2014) The epidemiology of multiple sclerosis: insights to disease pathogenesis. Handb Clin Neurol 122:231–266. https://doi.org/10.1016/B978-0-444-52001-2.00010-8

    Article  PubMed  Google Scholar 

  3. Ramagopalan SV, Sadovnick AD (2011) Epidemiology of multiple sclerosis. Neurol Clin 29:207–217. https://doi.org/10.1016/j.ncl.2010.12.010

    Article  PubMed  Google Scholar 

  4. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2

    Article  Google Scholar 

  5. Compston A (2006) Making progress on the natural history of multiple sclerosis. Brain 129:561–563

    Article  Google Scholar 

  6. Jokubaitis VG, Spelman T, Kalincik T, Lorscheider J, Havrdova E, Horakova D, Duquette P, Girard M, Prat A, Izquierdo G, Grammond P, Van Pesch V, Pucci E, Grand’Maison F, Hupperts R, Granella F, Sola P, Bergamaschi R, Iuliano G, Spitaleri D, Boz C, Hodgkinson S, Olascoaga J, Verheul F, McCombe P, Petersen T, Rozsa C, Lechner-Scott J, Saladino ML, Farina D, Iaffaldano P, Paolicelli D, Butzkueven H, Lugaresi A, Trojano M, MSBase Study Group (2016) Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol 80:89–100. https://doi.org/10.1002/ana.24682

    Article  PubMed  Google Scholar 

  7. Uher T, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Ramasamy D, Zivadinov R, Havrdova E, Kalincik T, Horakova D (2017) Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis. Mult Scler 23:51–61. https://doi.org/10.1177/1352458516642314

    Article  PubMed  Google Scholar 

  8. Tortorella P, Laganà MM, Saresella M, Tavazzi E, Preti MG, Ricci C, Baglio F, Marventano I, Piancone F, Baselli G, Cecconi P, Caputo D, Clerici M, Rovaris M (2014) Determinants of disability in multiple sclerosis: an immunological and MRI study. Biomed Res Int 2014:875768. https://doi.org/10.1155/2014/875768

    Article  PubMed  PubMed Central  Google Scholar 

  9. Gajofatto A, Calabrese M, Benedetti MD, Monaco S (2013) Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. Dis Markers 35:687–699. https://doi.org/10.1155/2013/484959

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tedeholm H, Skoog B, Lisovskaja V, Runmarker B, Nerman O, Andersen O (2015) The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset. J Neurol 262:1148–1163. https://doi.org/10.1007/s00415-015-7674-y

    Article  PubMed  Google Scholar 

  11. Russo M, Crupi D, Naro A, Avanzino L, Buccafusca M, Dattola V, Terranova C, Sottile F, Rizzo V, Ghilardi MF, Girlanda P, Bove M, Quartarone A (2015) Fatigue in patients with multiple sclerosis: from movement preparation to motor execution. J Neurol Sci 351:52–57. https://doi.org/10.1016/j.jns.2015.02.031

    Article  PubMed  Google Scholar 

  12. Ramsaransing G, Maurits N, Zwanikken C, De Keyser J (2001) Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 7:345–347. https://doi.org/10.1177/135245850100700512

    Article  CAS  PubMed  Google Scholar 

  13. Stewart T, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, Girard M, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Sola P, Shaygannejad V, Hupperts R, Alroughani R, Oreja-Guevara C, Pucci E, Boz C, Lechner-Scott J, Bergamaschi R, Van Pesch V, Iuliano G, Ramo C, Taylor B, Slee M, Spitaleri D, Granella F, Verheul F, McCombe P, Hodgkinson S, Amato MP, Vucic S, Gray O, Cristiano E, Barnett M, Sanchez Menoyo JL, van Munster E, Saladino ML, Olascoaga J, Prevost J, Deri N, Shaw C, Singhal B, Moore F, Rozsa C, Shuey N, Skibina O, Kister I, Petkovska-Boskova T, Ampapa R, Kermode A, Butzkueven H, Jokubaitis V, Kalincik T, MSBase Study Group (2017) Contribution of different relapse phenotypes to disability in multiple sclerosis. Mult Scler 23:266–276. https://doi.org/10.1177/1352458516643392

    Article  PubMed  Google Scholar 

  14. Kalron A, Givon U (2016) Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis. J Neurol 263:1796–1801. https://doi.org/10.1007/s00415-016-8200-6

    Article  PubMed  Google Scholar 

  15. Muccilli A, Seyman E, Oh J (2018) Spinal cord MRI in multiple sclerosis. Neurol Clin 36:35–57. https://doi.org/10.1016/j.ncl.2017.08.009

    Article  PubMed  Google Scholar 

  16. Dunn SE, Gunde E, Lee H (2015) Sex-based differences in multiple sclerosis (MS): part II: rising incidence of multiple sclerosis in women and the vulnerability of men to progression of this disease. Curr Top Behav Neurosci 26:57–86. https://doi.org/10.1007/7854_2015_370

    Article  CAS  PubMed  Google Scholar 

  17. Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C, Comabella M, Nos C, Arévalo MJ, Negrotto L, Galán I, Vidal-Jordana A, Castilló J, Palavra F, Simon E, Mitjana R, Auger C, Sastre-Garriga J, Montalban X (2015) Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 138:1863–1874. https://doi.org/10.1093/brain/awv105

    Article  PubMed  Google Scholar 

  18. Damasceno A, Von Glehn F, Brandão CO, Damasceno BP, Cendes F (2013) Prognostic indicators for long-term disability in multiple sclerosis patients. J Neurol Sci 324:29–33. https://doi.org/10.1016/j.jns.2012.09.020

    Article  PubMed  Google Scholar 

  19. Rojas JI, Sánchez F, Patrucco L, Miguez J, Funes J, Cristiano E (2016) Structural sex differences at disease onset in multiple sclerosis patients. Neuroradiol J 29:368–371. https://doi.org/10.1177/1971400916666560

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kister I, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Herbert J (2013) Natural history of multiple sclerosis symptoms. Int J MS Care 15:146–158. https://doi.org/10.7224/1537-2073.2012-053

    Article  PubMed  PubMed Central  Google Scholar 

  21. Patejdl R, Penner IK, Noack TK, Zettl UK (2016) Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun Rev 15:210–220. https://doi.org/10.1016/j.autrev.2015.11.005

    Article  CAS  PubMed  Google Scholar 

  22. van den Vuurst de Vries RM, van den Dorpel JJ, Mescheriakova JY, Runia TF, Jafari N, Siepman TA, Rizopoulos D, Steyerberg EW, Hintzen RQ (2018) Fatigue after a first attack of suspected multiple sclerosis. Mult Scler 24:974–981. https://doi.org/10.1177/1352458517709348

    Article  PubMed  Google Scholar 

  23. Vaughn CB, Kavak KS, Dwyer MG, Bushra A, Nadeem M, Cookfair DL, Ramanathan M, Benedict RH, Zivadinov R, Goodman A, Krupp L, Motl RW, Weinstock-Guttman B, New York State Multiple Sclerosis Consortium (2018) Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium. Mult Scler. https://doi.org/10.1177/1352458518816619

    Article  PubMed  Google Scholar 

  24. Šabanagić-Hajrić S, Suljić E, Kučukalić A (2015) Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability. Psychiatr Danub 27:406–412

    PubMed  Google Scholar 

Download references

Funding

There was no external source of funding.

Author information

Authors and Affiliations

  1. Department of Neurology and Neurosurgery, Odessa National Medical University, Odesa, Ukraine

    Alina Ivaniuk, Yuliia Solodovnikova, Tetiana Marusich & Anatoliy Son

Authors
  1. Alina Ivaniuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuliia Solodovnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetiana Marusich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anatoliy Son
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization: AI, YS, AS; Methodology: AI, YS; Formal analysis and investigation: AI, TM; Writing—original draft preparation: AI; Writing—review and editing: YS, TM, AS; Supervision: YS, AS.

Corresponding author

Correspondence to Alina Ivaniuk.

Ethics declarations

Ethics approval

Ethical approval was waived by the local Ethics Committee in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.

Consent for publication

Not applicable.

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ivaniuk, A., Solodovnikova, Y., Marusich, T. et al. The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing–remitting multiple sclerosis differently in female and male patients. Acta Neurol Belg 121, 1699–1706 (2021). https://doi.org/10.1007/s13760-020-01478-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-020-01478-0

Keywords

Search

Navigation